BCWM
BIO icon

Bartlett & Co Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bartlett & Co Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11
Closed -$2.65K – 1210
2025
Q2 		$2.65K Buy
+11
New +$2.6K ﹤0.01% 1069

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bartlett & Co Wealth Management's BIO Position: Q3 2025 in Review

Bartlett & Co Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2025, closing a stake of 11 shares — an estimated $2.65K sold.

Bartlett & Co Wealth Management first reported a position in BIO in Q2 2025 and held it in 1 quarter. The position peaked at $2.65K in Q2 2025. 396 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

  • Bartlett & Co Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2025 after selling out during the quarter.
  • Bartlett & Co Wealth Management sold 11 Bio-Rad Laboratories Class A shares in Q3 2025, an estimated $2.65K.
  • Bartlett & Co Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q2 2025 and held it in 1 quarter.
  • Bartlett & Co Wealth Management's Bio-Rad Laboratories Class A position peaked at $2.65K in Q2 2025.
  • 396 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on Bartlett & Co Wealth Management's 13F filing for Q3 2025, filed 9 Oct 2025.